4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-005572
CEO sold 5,577 shares at $24.67 ($137,585)
- CEO acquired 10,946 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2024-02-23 | Option exercise | +10,946 | 107,467 | D | ||
| DAVIS STEPHEN CEO | 2024-02-26 | Sale | −5,577 | $24.67 | $137,585 | 101,890 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2024-02-23 | Option exercise · Restricted Stock Units | −10,946 | 10,946 | D | ||
| Open-market sales · 5,577 sh · avg $24.67 · $137,585 | |||||||
Loading xslF345X05/form4-02272024_110210.xml…